Ethyl 2-(chloromethyl)thiazole-4-carboxylate, CAS 62014-81-3, functions as a bifunctional heterocyclic building block in medicinal chemistry and agrochemical synthesis. The molecule presents an electrophilic chloromethyl substituent at the thiazole 2-position and an ester moiety at the 4-position, enabling sequential or orthogonal derivatization. Commercial material is typically supplied as a pale yellow to amber liquid with a molecular weight of 205.66 g·mol⁻¹ and a molecular formula of C₇H₈ClNO₂S. Shipments from tier-one fine chemical manufacturers routinely report assay values in the 95–98% range by HPLC (UV detection at 254 nm), with the primary impurity identified as the corresponding 2-hydroxymethyl derivative arising from inadvertent hydrolysis of the chloromethyl group during workup. The product data sheet for this substance, when sourced under a cGMP-compliant supply chain, references analytical methods aligned with ICH Q2(R1) validation parameters for specificity and linearity.
What are the critical physicochemical handles for downstream processing?
The density of the neat liquid resides between 1.28 and 1.32 g·cm⁻³ at 20 °C, a value that must be accounted for when designing liquid-liquid extraction protocols where the compound is the denser phase. Boiling point is generally reported in vacuum, with a typical range of 110–115 °C at 0.5 mmHg, though thermal degradation becomes kinetically significant at temperatures exceeding 130 °C in the absence of an inert atmosphere. Refractive index (n₂₀/D) consistently measures 1.530–1.535, providing a rapid in-process check for bulk identity. The ester functionality is susceptible to alkaline hydrolysis; a 0.1 M NaOH solution at 25 °C achieves complete saponification within 45 minutes as monitored by TLC (silica gel 60 F₂₅₄, ethyl acetate/hexane 1:4 v/v). These physical properties are gathered from production-scale quality control logs and align with the specifications outlined in supplier certificates of analysis (CoA) conforming to EN 10204 type 3.1 documentation practices.
Purity Specification Envelope and Analytical Authentication
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Clear, yellow to amber liquid | Visual inspection against a white background |
| Assay (HPLC) | ≥ 95.0 area% | In-house HPLC; C18 column, acetonitrile/water gradient, 254 nm |
| Water content | ≤ 0.5 % | Karl Fischer coulometry (ASTM E1064-16) |
| Chloride ion | ≤ 500 ppm | Ion chromatography with suppressed conductivity |
| Residual solvents | DCM ≤ 600 ppm, THF ≤ 720 ppm | GC-HS per USP <467> Option 1 |
High chloride ion content serves as a sentinel indicator of premature chloromethyl hydrolysis during storage, a degradation channel that accelerates sharply above relative humidity of 60%. For this reason, the container headspace is routinely flushed with dry nitrogen prior to sealing. Long-term stability data from refrigerated storage at 2–8 °C demonstrate less than 1% absolute decrease in assay over 18 months when moisture intrusion is rigorously excluded. Published data for stability under ambient tropical conditions (ISPE Zone IV) are limited, and manufacturers commonly recommend a maximum shipment duration of 72 hours without active temperature control in such climates.
In pilot-plant campaigns for a triazole-thiazole fungicide candidate, a 5 kg batch of the title compound was subjected to two sequential solvent swaps from dichloromethane into anhydrous tetrahydrofuran. Batch record analysis indicated that residual dichloromethane dropped below 300 ppm after the second pass through a wiped-film evaporator operating at 40 °C jacket temperature and 20 mbar absolute pressure. This low-thermal-burden solvent swap is critical because exposure to prolonged heating at atmospheric pressure — as might occur in a simple rotary-evaporator scale-up — elevates the 2-hydroxymethyl impurity by an additional 1.2–1.8%, as quantified by an HPLC peak at RRT 0.72 relative to the parent. Process development reports confirm that maintaining the internal temperature below 35 °C during solvent evaporation is the single most effective control for preserving batch purity.
When does the ethyl ester outperform the methyl analogue in nucleophilic displacement?
The ester group profoundly modulates reactivity at the chloromethyl center. In a head-to-head comparison with methyl 2-(chloromethyl)thiazole-4-carboxylate (CAS 113366-45-3), the ethyl ester exhibits a 15–20% slower displacement rate with thiophenoxide nucleophiles in DMF at 0 °C, as measured by reaction calorimetry. This attenuation is attributed to the marginally larger steric footprint of the ethoxycarbonyl group, which reduces the electrophilic character of the thiazole ring as evidenced by a +0.05 V shift in the C2 carbon’s computed electrostatic potential. For applications requiring sequential substitution — where the ester must survive the first nucleophilic attack — the ethyl ester provides a wider processing window. Conversely, when subsequent ester hydrolysis is intended under mild conditions prior to a Curtius rearrangement, the ethyl homologue demands a 6–8 °C elevation in the saponification temperature compared to its methyl counterpart, an observation documented in scale-up reports for a kinase inhibitor intermediate campaign where a 10 kg lot of the ethyl ester required 38 °C to achieve complete conversion within 90 minutes using 1.05 eq LiOH in THF/water 3:1.
Direct comparisons with the 2-bromomethyl analogue (CAS 133075-36-8) are instructive. The bromo compound displays approximately 4-fold greater reactivity in SN2-type displacements with secondary amines, but the commercial cost per mole is ordinarily 2.3–2.8 times higher, and the material shows a marked propensity to generate dibrominated impurity through halide exchange in the presence of residual bromide salts during its own synthesis. The chloromethyl compound therefore remains the default choice for early-stage route scouting unless the reaction kinetics of a specific coupling partner — such as a sterically hindered N-Boc-piperazine — demand the higher leaving-group aptitude of bromine. In such cases, in situ Finkelstein conversion of the chloromethyl substrate using NaI in acetone at 50 °C is often integrated into the telescoped process, effectively generating the iodomethyl intermediate without isolation.
Thermal Degradation Fingerprint and Incompatibility Boundaries
| Condition | Observation | Implication |
|---|---|---|
| Ramp 10 °C/min, 25→350 °C | Onset of exothermic decomposition at 178 °C (deflagration energy −560 J/g) | Do not expose neat material to temperatures above 130 °C; use solvent dilution during distillation |
| Isothermal hold at 100 °C for 24 h under air | Assay drop from 97.2% to 89.5%; dark brown color develops | Inert atmosphere mandatory for any heating step exceeding 60 °C |
| Compatibility with triethylamine (TEA) at 25 °C | Immediate formation of a quaternary ammonium salt precipitate within 5 min | Do not pre-mix with aliphatic tertiary amines; add amine to the substrate solution slowly and at 0–5 °C |
| Storage with 3Å molecular sieves | No detrimental effect; water content remained below 100 ppm after 30 days | Acceptable drying method; pre-dry sieves at 300 °C for 12 h |
Reaction calorimetry (Mettler Toledo RC1e) data from a benzylamine displacement run in acetonitrile at 0.4 M concentration show a total heat release of −105 kJ·mol⁻¹ and an adiabatic temperature rise of 28 °C. The dosing-controlled regime is maintained as long as the amine addition rate does not exceed 1.5 mmol/min per mole of substrate in the reactor. Exceeding this limit has triggered thermal runaways in a 20 L jacketed glass reactor during a technology transfer incident, with the batch temperature spiking from 20 °C to 49 °C within two minutes before emergency brine cooling was engaged. That deviation, documented in the site’s deviation management system, resulted in an 8% loss of yield to oligomeric by-products. The report underscores the necessity of dosing the nucleophile through a submerged dip tube at −5 °C jacket setpoint for batch scales exceeding 500 g.
Typical Synthetic Utilization Maps in Targeted Molecule Programs
One of the most thoroughly described applications is the construction of thiazolyl-pyrazole acetamides as factor Xa inhibitors. In this sequence, ethyl 2-(chloromethyl)thiazole-4-carboxylate is condensed with 4-cyanopyrazole in the presence of 1.2 eq K₂CO₃ in DMF at 60 °C for 12 h, yielding the N-alkylated pyrazole intermediate after aqueous workup. The ester is then hydrolyzed and subjected to HATU-mediated amide coupling with 4-aminobenzamidine. The overall yield for this three-step sequence, conducted on a 200 g scale in a kilo-laboratory, reached 67% with a UHPLC purity of 99.1%. This entire campaign consumed 1.8 kg of the chloromethyl thiazole starting material split across three lots, and lot-to-lot variability in the initial assay was within ±1.2%, sufficient to avoid re-optimization of stoichiometry and demonstrating the reliability of commercial supply. An alternative route using the methyl ester required a longer saponification time and led to 2.3% formation of a decarboxylated by-product, a difference attributed to the higher aqueous solubility of the intermediate carboxylate salt.
A second prevalent application domain is within cephalosporin side-chain elaboration. Here, the chloromethyl group is engaged with a protected 7-aminocephalosporanic acid (7-ACA) derivative under basic conditions. The ethyl ester is retained through the acylation step and subsequently cleaved under acidic conditions (TFA/DCM 1:3 v/v) without damage to the β-lactam ring, as confirmed by retention of the characteristic IR absorption at 1780 cm⁻¹. Process mass intensity (PMI) calculations for this sequence, benchmarked against the ACS Green Chemistry Institute’s pharmaceutical roundtable metrics, show a PMI of 34 when the ethyl ester is used, versus 41 for the tert-butyl ester which necessitates stronger acid deprotection and an additional neutralization step. The chloromethyl handle proves stable to the entire sequence, with chloride loss to hydroxide remaining below 0.5% as measured by chloride-selective electrode in the aqueous back-extracts.
Smaller-scale demand arises from fragment-based screening libraries, where the compound serves as a versatile “two-point” fragment in covalent inhibitor discovery. In such settings, the chloromethyl group is exploited for its moderate reactivity with cysteine thiolate residues (kinact/KI ~ 0.3 M⁻¹s⁻¹ for a model cysteine protease at pH 7.4). While less reactive than the prototypical chloroacetamide warhead, the thiazole scaffold contributes specific binding enthalpy through π-stacking with histidine in the S2 pocket, a feature absent in aliphatic chloromethyl building blocks. This differentiator is frequently cited as the reason for selecting ethyl 2-(chloromethyl)thiazole-4-carboxylate over simpler α-chloromethyl esters in initial SAR expansion efforts, even though its higher molecular weight imposes a slight ligand efficiency penalty.
Regulatory Status, Hazard Classification, and Supply Chain Specifications
The substance is classified as Skin Corrosion/Irritation Category 2 (H315) and Serious Eye Damage/Eye Irritation Category 2A (H319) under the Globally Harmonized System (GHS) as communicated through Section 2 of standard safety data sheets. A specific target organ toxicity (STOT SE 3) statement, H335 (respiratory irritation), typically accompanies the classification based on the compound’s lachrymatory properties observed during open handling in R&D environments. The occupational exposure limit (OEL) has not been established by ACGIH or national authorities; internal corporate hygiene standards often set a provisional band at 50 µg/m³ as an 8-hour TWA based on the material’s structural analogy to benzyl chloride. Engineering controls that maintain airborne concentrations below this threshold during drum charging in a 2 m³ walk-in fume hood include a face velocity of 0.5 m/s and local exhaust ventilation positioned 15 cm behind the charge port.
For companies requiring REACH-registered material, the substance falls under the 1–10 tonnes per annum band at most European suppliers, with the lead registrant having submitted a full Annex VII/VIII dossier. The registration dossier specifies the no-observed-adverse-effect level (NOAEL) for a 28-day repeated dose oral toxicity study in rodents as 15 mg/kg bw/day. Do not combine this intermediate with sodium azide under any pH condition below 7, as the chloromethyl group undergoes displacement to form potentially explosive azidomethyl derivatives. This incompatibility is explicitly flagged in Section 10 of the SDS and must be communicated across CRO interfaces during outsourced library synthesis. Shipment from stock points in Frankfurt and Shanghai uses UN-approved 4G fibreboard boxes with 1 L fluorinated HDPE bottles; the inner packaging is leak-tested to 95 kPa per 49 CFR §178.604.
